| 英文别名 |
Docosan-1-ol;ALCOHOL C22;BEHENYL ALCOHOL;DOCOSANOL;DOCOSANOL, N-;JARCOL 22;N-DOCOSANOL;Behenic alcohol;Cachalot BE-22;Dehydag wax 22 (lanette);Docosanol-(1);Docosyl alcohol;Emery 3304;ik2;lidavol;Loxiol VPG 1451;tadenan;1-Docosanol;DOCOSANOL, n-(P) PrintBack;Docosanol (Abreua);docosanyl alcohol;Abreva;Lanette 22;Lidakol;Stenol 1822A;Stenol 1822;Docosanol [USAN];IK 2;Docosanol (VAN);NAA 422;IK.2;Docosanol (Abreva);Docosanol (USAN);C22H46O;9G1OE216XY;NOPFSRXAKWQILS-UHFFFAOYSA-N;M;Behenyl alcohol;Herepair;Herepair;BRD-K50050533-001-03-9;BRD-K50050533-001-03-9;CHEMBL1200453;CHEMBL1200453;LMFA05000008;LMFA05000008;HY-B0222;HY-B0222;NSC759235;NSC759235;s1637;s1637;A3D72D45-625E-49B5-B0FC-394010B3485D;A3D72D45-625E-49B5-B0FC-394010B3485D;DOCOSANOL (MART.);DOCOSANOL (MART.);1-Docosanol, purum, >=97.0% (GC);1-Docosanol, purum, >=97.0% (GC);AB01563123_02;AB01563123_02;EINECS 211-546-6;EINECS 211-546-6;DOCOSANOL [WHO-DD];DOCOSANOL [WHO-DD];Lidavol;Lidavol;NSC 8407;NSC 8407;AC-19852;AC-19852;Docosanol;Docosanol;Abreva (TN);Abreva (TN);docosan-1-ol;docosan-1-ol;1-DOCOSANOL;1-DOCOSANOL;NCGC00159370-04;NCGC00159370-04;N-DOCOSANOL [MI];N-DOCOSANOL [MI];30303-65-2;30303-65-2;D03884;D03884;EC 211-546-6;EC 211-546-6;NCGC00159370-03;SR-05000001915-1;NCGC00159370-03;AKOS015902887;SR-05000001915-1;DB00632;AKOS015902887;BRD-K50050533-001-04-7;DB00632;Q3033497;BRD-K50050533-001-04-7;DOCOSANOL [MART.];Q3033497;Healip;DOCOSANOL [MART.];Tadenan;Healip;DTXCID907286;Tadenan;CAS-661-19-8;DTXCID907286;Cold Sore Fever Blister Treatment;CAS-661-19-8;NCGC00159370-02;Cold Sore Fever Blister Treatment;SCHEMBL51925;NCGC00159370-02;BRN 1770470;SCHEMBL51925;DOCOSANOL [VANDF];BRN 1770470;HMS2093P22;DOCOSANOL [VANDF];Pharmakon1600-01505729;NCGC00159370-05;HMS2093P22;DA-69546;Pharmakon1600-01505729;Behenyl alcohol, AI3-36489, Behenic alcohol, 1-Docosanol, Docosyl alcohol, IK-2, Tadenan;NCGC00159370-05;NSC-8407;DA-69546;Nacol 22-97;Behenyl alcohol, AI3-36489, Behenic alcohol, 1-Docosanol, Docosyl alcohol, IK-2, Tadenan;1-Docosanol, 98%;NSC-8407;DOCOSANOL (II);Nacol 22-97;Erazaban;1-Docosanol, 98%;Tox21_111611;DOCOSANOL (II);NSC-759235;Erazaban;DTXSID4027286;Tox21_111611;AI3-36489;NSC-759235;D70615;DTXSID4027286;SBI-0206938.P001;AI3-36489;Cold Sore Fever Blister;D70615;DOCOSANOL [ORANGE BOOK];SBI-0206938.P001;CCG-213539;Cold Sore Fever Blister;InChI=1/C22H46O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23/h23H,2-22H2,1H;DOCOSANOL [ORANGE BOOK];DOCOSANOL [II];CCG-213539;HSDB 5739;InChI=1/C22H46O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23/h23H,2-22H2,1H;CHEBI:31000;DOCOSANOL [II];SR-05000001915;HSDB 5739;UNII-9G1OE216XY;NS00009524;CHEBI:31000;DOCOSANOL [HSDB];SR-05000001915;CCRIS 8943;UNII-9G1OE216XY;4-01-00-01906 (Beilstein Handbook Reference);NS00009524;D0964;DOCOSANOL [HSDB];MFCD00002939;CCRIS 8943;NSC8407;4-01-00-01906 (Beilstein Handbook... |
微信公众号
客服
